Výsledky vyhledávání - "Peripheral blood stem cell rescue"

Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children

Autor: Carol Fries, David N. Korones, Angela R Girvin, Lauren Weintraub, Lorna K. Fitzpatrick, Jeffrey R. Andolina

Publikováno v: Journal of Pediatric Hematology/Oncology. 43:e1223-e1227

Malignant central nervous system (CNS) tumors in young children have a poor prognosis and pose a therapeutic challenge. We describe 11 patients with high-risk CNS tumors (6 atypical teratoid/rhabdoid tumor, 4 nonmedulloblastoma CNS embryonal tumors,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12200117dd652061106d32ce23f99885
https://doi.org/10.1097/mph.0000000000002198

Zobrazit plný text záznamu

AS1-KL-1 DEVELOPMENT OF HIGH-DOSE CHEMOTHERAPY INCLUDING THIOTEPA COMBINED WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL RESCUE

Autor: Junichi Hara

Publikováno v: Neuro-oncology Advances

Thiotepa is a classic alkylating agent that was launched in 1958 in Japan. We have consistently developed thiotepa-containing HDC since 1992, inspired by the fact that thiotepa was used as an alternative to melphalan as a high-dose chemotherapy (HDC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac45ea1972318866882bdaff90d47310
http://europepmc.org/articles/PMC7213138

Zobrazit plný text záznamu

Purging marrow or peripheral blood stem cells for autografting

Autor: Edward D. Ball, Lisa C. Hammert

Publikováno v: Current Opinion in Hematology. 4:423-428

Myeloablative therapy followed by autologous bone marrow or peripheral blood stem cell rescue is an alternative therapeutic option for patients who are not candidates for allogeneic transplantation due to the lack of an appropriate HLA-matched donor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c29198f4e1a1773f26a0d6dced93d77
https://doi.org/10.1097/00062752-199704060-00011

Zobrazit plný text záznamu

Hemorrhagic lymphadenopathy as a presenting feature of primary al amyloidosis

Autor: John P. Hanley, Fergus R. MacLean, Bridget A. Robinson, B. M. Colls, W. Nigel Patton, Jane L. Evans, D. C. Heaton

Publikováno v: Pathology. 32:21-23

Lymphadenopathy associated with hemorrhage as a presenting feature of primary (AL) amyloidosis has not previously been described. We report two such cases one of whom had an acquired factor X and IX deficiency. The clinical presentations were charact

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8170fb2fef744ac9e62745063e67f1
https://doi.org/10.1080/003130200104510

Zobrazit plný text záznamu

High-dose chemotherapy and autologous peripheral blood stem cell rescue (Auto-SCT) in multiple myeloma (MM) patients: Busulfan + melphalan-140 (BuMel) versus (vs) melphalan-200 (Mel-200) as conditioning regimens

Autor: Alfonso Gomez-Pineda, Ana Pérez-Corral, Pascual Balsalobre, I. Buno, M. Mayayo, Javier Anguita, R. Carrion Galindo, David P. Serrano, José Luis Díez-Martín

Publikováno v: Journal of Clinical Oncology. 24:7612-7612

7612 Background: Auto-SCT is the preferred treatment modality for MM. From the results of IFM 9502 (Moreau et al. Blood, 2002) melphalan 200 mg/m2 was considered the new standard as conditioning regimen due to its lower toxicity. However, many chemot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4dff905e9a89411bfeae4e487fd438bc
https://doi.org/10.1200/jco.2006.24.18_suppl.7612

Zobrazit plný text záznamu

Outcome for children ≤3 years of age with malignant brain or spinal cord tumors treated with high dose chemotherapy with peripheral blood stem cell rescue

Autor: E. Perez, Tobey J. MacDonald, Roger J. Packer, Naynesh Kamani, Deborah Lafond, B. Loechelt, B. Rood, H. K. Thorarinsdottir

Publikováno v: Journal of Clinical Oncology. 23:8552-8552

8552 Background: Children ≤3 years of age (yo) with malignant brain tumors have a dismal prognosis. In a POG study starting in 1986 (NEJM Jun ’93), 102 patients had a 1 and 2 year progression free ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::918a5c7294b98e6da140fc6d354cf4b6
https://doi.org/10.1200/jco.2005.23.16_suppl.8552

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání